Iodine-131 Rituximab Radioimmunotherapy with BEAM Conditioning and Autologous Stem Cell Transplant Salvage Therapy for Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Iodine-131 Rituximab Radioimmunotherapy with BEAM Conditioning and Autologous Stem Cell Transplant Salvage Therapy for Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
Authors
Keywords
-
Journal
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
Volume 27, Issue 9, Pages 552-560
Publisher
Mary Ann Liebert Inc
Online
2012-10-13
DOI
10.1089/cbr.2012.1275
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of radioimmunotherapy for consolidation for chemosensitive mantle cell lymphoma (MCL): Summary of International Radioimmunotherapy Registry data.
- (2017) W. Jurczak et al. JOURNAL OF CLINICAL ONCOLOGY
- A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma
- (2012) Avichai Shimoni et al. CANCER
- Cytogenetic Risk Stratification in Myelodysplastic Syndromes: Are We There Yet?
- (2012) Animesh Pardanani et al. JOURNAL OF CLINICAL ONCOLOGY
- Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with 131I-anti-CD20 antibody and stem cell rescue
- (2011) Karin Hohloch et al. ANNALS OF HEMATOLOGY
- 90Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma
- (2011) A. K. Gopal et al. BLOOD
- 90Y Ibritumomab Tiuxetan (Zevalin) Combined With BEAM (Z -BEAM) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed or Refractory Low-grade CD20-positive B-cell Lymphoma. A GELA Phase II Prospective Study
- (2011) Didier Decaudin et al. Clinical Lymphoma Myeloma & Leukemia
- Neutropenia after rituximab treatment
- (2011) Ofir Wolach et al. CURRENT OPINION IN HEMATOLOGY
- Time To Remember To Forget Dose-Intensification in Lymphoma
- (2011) Bruce D. Cheson JOURNAL OF CLINICAL ONCOLOGY
- Rituximab-induced late onset neutropenia in newly-diagnosed B-cell lymphoma correlates with Fc receptor FcγRIIIa 158(V/F) polymorphism
- (2010) Szu-Chin Li et al. AMERICAN JOURNAL OF HEMATOLOGY
- Radioimmunotherapy of relapsed indolent non-Hodgkin lymphoma with 131I-rituximab in routine clinical practice: 10-year single-institution experience of 142 consecutive patients
- (2010) M. F. Leahy et al. BLOOD
- Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
- (2010) B. Coiffier et al. BLOOD
- Rituximab
- (2010) Gillian M. Keating DRUGS
- Rituximab Maintenance Treatment of Relapsed/Resistant Follicular Non-Hodgkin's Lymphoma: Long-Term Outcome of the EORTC 20981 Phase III Randomized Intergroup Study
- (2010) Marinus H.J. van Oers et al. JOURNAL OF CLINICAL ONCOLOGY
- Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
- (2010) Christian Gisselbrecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Yttrium-90 Ibritumomab Tiuxetan Doses Calculated to Deliver up to 15 Gy to Critical Organs May Be Safely Combined With High-Dose BEAM and Autologous Transplantation in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
- (2009) Jane N. Winter et al. JOURNAL OF CLINICAL ONCOLOGY
- Expert Opinions on Positron Emission Tomography and Computed Tomography Imaging in Lymphoma
- (2009) D. Delbeke et al. ONCOLOGIST
- Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab
- (2008) M. J. Bishton et al. ANNALS OF ONCOLOGY
- High-Dose Yttrium-90–Ibritumomab Tiuxetan With Tandem Stem-Cell Reinfusion: An Outpatient Preparative Regimen for Autologous Hematopoietic Cell Transplantation
- (2008) Liliana Devizzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Evidence Mounts for the Efficacy of Radioimmunotherapy for B-Cell Lymphomas
- (2008) Oliver W. Press JOURNAL OF CLINICAL ONCOLOGY
- A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
- (2007) E. Hoster et al. BLOOD
- Phase II Trial of a Transplantation Regimen of Yttrium-90 Ibritumomab Tiuxetan and High-Dose Chemotherapy in Patients With Non-Hodgkin's Lymphoma
- (2007) Amrita Krishnan et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started